Rivaroxaban combined with spironolactone attenuates cardiovascular remodeling due to hypoxia in pulmonary arterial hypertension

被引：0
|
作者：
Hayashi, T. [1 ]
Matsumoto, S. [1 ]
Hosokawa, A. [1 ]
Yamamoto, K. [1 ]
Nomura, A. [1 ]
Woo, E. [2 ]
Imano, H. [1 ]
Kato, R. [1 ]
Ijiri, Y. [1 ]
Yamaguchi, T. [3 ]
Izumi, Y. [3 ]
Yoshiyama, M. [3 ]
Okada, Y. [2 ]
Asahi, M. [2 ]
机构：
[1] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka, Japan
[2] Osaka Med Coll, Takatsuki, Osaka, Japan
[3] Osaka City Univ, Osaka, Japan
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2501
引用
收藏
页码：485 / 485
页数：1
相关论文
共 50 条
  • [41] Deubiquitinase BRCC36 inhibits hypoxia-induced pulmonary arterial hypertension and remodeling
    Shen, Hui
    Yao, Deshan
    Zhang, Lina
    Zhang, Zhengang
    Gong, Kaizheng
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 140 : 35 - 35
  • [42] RIVAROXABAN ATTENUATES CARDIAC REMODELING DUE TO INTERMITTENT HYPOXIA BY SUPPRESSING THE SYNERGISTIC EFFECTS OF PAR-1 AND PAR-2
    Mitsuishi, Rintaro
    Imano, Hideki
    Kato, Ryuji
    Ijiri, Yoshio
    Yamaguchi, Takehiro
    Yoshiyama, Minoru
    Hayashi, Tetsuya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2033 - 2033
  • [43] Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection
    Zhu, Rong
    Bi, Li-Qing
    Wu, Su-Ling
    Li, Lan
    Kong, Hui
    Xie, Wei-Ping
    Wang, Hong
    Meng, Zi-Li
    MOLECULAR MEDICINE REPORTS, 2015, 12 (02) : 2945 - 2952
  • [44] Inhibition of YAP1 Via Verteporfin Attenuates Hypoxia- or Hypoxia Sugen Mediated Pulmonary Hypertension and Pulmonary Vascular Remodeling in Rodents
    Chen, J.
    Zhao, S.
    Wang, Y.
    Felesena, N.
    Huang, L.
    Machado, R. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [45] Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
    Andersen, Kasper Hasseriis
    Andersen, Claus Bogelund
    Gustafsson, Finn
    Carlsen, Jorn
    PULMONARY CIRCULATION, 2017, 7 (02) : 514 - 521
  • [46] REPRODUCIBILITY OF IN VIVO PULMONARY ARTERIAL REMODELING ASSESSMENT IN STABLE PULMONARY ARTERIAL HYPERTENSION
    Domingo, Enric
    Calabuig, Alvaro
    Manuel, Lopez-Messeguer
    Perez-Hoyos, Santiago
    Bravo, Carlos
    Serra, Bernat
    Grignola, Juan
    Kendall, Lindsay
    Cahn, Tony
    Fowles, Susan
    Wilson, Fred
    Roman, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1937 - 1937
  • [47] Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
    Leopold, Jane A.
    Maron, Bradley A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [48] CGRP attenuates pulmonary vascular remodeling by inhibiting the cGAS-STING-NFκB pathway in pulmonary arterial hypertension
    Yan, Xin
    Huang, Jun
    Zeng, Youjie
    Zhong, Xuefeng
    Fu, Yangxia
    Xiao, Haiyan
    Wang, Xia
    Lian, Huilin
    Luo, Hui
    Li, Dai
    Guo, Ren
    BIOCHEMICAL PHARMACOLOGY, 2024, 222
  • [49] PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation
    Shimizu, Takashi
    Higashijima, Yoshiki
    Kanki, Yasuharu
    Nakaki, Ryo
    Kawamura, Takeshi
    Urade, Yoshihiro
    Wada, Youichiro
    SCIENCE SIGNALING, 2021, 14 (667)
  • [50] Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice
    Liu, Hong
    Wang, Yuxiang
    Zhang, Qingqing
    Liu, Chuanchuan
    Ma, Yougang
    Huang, Pan
    Lan, Rili
    Ma, Lan
    IMMUNOLOGY LETTERS, 2023, 263 : 113 - 122
12345